Miz1 was recently characterized as an important regulator of HCC progression within hepatocytes, where its absence results in the activation of anti-inflammatory TAMs due to a lack of metadherin-MTDH-mediated (a coactivator) NF-κB inhibition [95]. The gene discussed is MTDH; the disease is hepatocellular carcinoma.